526 related articles for article (PubMed ID: 31742339)
1. Risk of gastrointestinal bleeding associated with oral anticoagulation and non-steroidal anti-inflammatory drugs in patients with atrial fibrillation: a nationwide study.
Olsen AS; McGettigan P; Gerds TA; Fosbøl EL; Olesen JB; Sindet-Pedersen C; Staerk L; Lock Hansen M; Pallisgaard JL; Køber L; Torp-Pedersen C; Gislason GH; Lamberts M
Eur Heart J Cardiovasc Pharmacother; 2020 Sep; 6(5):292-300. PubMed ID: 31742339
[TBL] [Abstract][Full Text] [Related]
2. The Risk of Gastrointestinal Bleeding between Non-Vitamin K Antagonist Oral Anticoagulants and Vitamin K Antagonists in the Asian Atrial Fibrillation Patients: A Meta-Analysis.
Yang KT; Sun WC; Tsai TJ; Tsay FW; Chen WC; Cheng JS
Int J Environ Res Public Health; 2020 Dec; 18(1):. PubMed ID: 33375495
[No Abstract] [Full Text] [Related]
3. Risk of major bleeding and stroke associated with the use of vitamin K antagonists, nonvitamin K antagonist oral anticoagulants and aspirin in patients with atrial fibrillation: a cohort study.
Gieling EM; van den Ham HA; van Onzenoort H; Bos J; Kramers C; de Boer A; de Vries F; Burden AM
Br J Clin Pharmacol; 2017 Aug; 83(8):1844-1859. PubMed ID: 28205318
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and Safety of the Use of Non-Vitamin K Antagonist Oral Anticoagulants in Patients With Nonvalvular Atrial Fibrillation and Concomitant Aspirin Therapy: A Meta-Analysis of Randomized Trials.
Bennaghmouch N; de Veer AJWM; Bode K; Mahmoodi BK; Dewilde WJM; Lip GYH; Brueckmann M; Kleine E; Ten Berg JM
Circulation; 2018 Mar; 137(11):1117-1129. PubMed ID: 29101289
[TBL] [Abstract][Full Text] [Related]
5. Antithrombotic therapy use in patients with atrial fibrillation before the era of non-vitamin K antagonist oral anticoagulants: the Global Registry on Long-Term Oral Antithrombotic Treatment in Patients with Atrial Fibrillation (GLORIA-AF) Phase I cohort.
Huisman MV; Ma CS; Diener HC; Dubner SJ; Halperin JL; Rothman KJ; Teutsch C; Schoof N; Kleine E; Bartels DB; Lip GY;
Europace; 2016 Sep; 18(9):1308-18. PubMed ID: 27335063
[TBL] [Abstract][Full Text] [Related]
6. Concomitant Use of NSAIDs or SSRIs with NOACs Requires Monitoring for Bleeding.
Lee MT; Park KY; Kim MS; You SH; Kang YJ; Jung SY
Yonsei Med J; 2020 Sep; 61(9):741-749. PubMed ID: 32882758
[TBL] [Abstract][Full Text] [Related]
7. Stroke and bleeding with non-vitamin K antagonist oral anticoagulant or warfarin treatment in patients with non-valvular atrial fibrillation: a population-based cohort study.
Forslund T; Wettermark B; Andersen M; Hjemdahl P
Europace; 2018 Mar; 20(3):420-428. PubMed ID: 28177459
[TBL] [Abstract][Full Text] [Related]
8. Relation of nonsteroidal anti-inflammatory drugs to serious bleeding and thromboembolism risk in patients with atrial fibrillation receiving antithrombotic therapy: a nationwide cohort study.
Lamberts M; Lip GY; Hansen ML; Lindhardsen J; Olesen JB; Raunsø J; Olsen AM; Andersen PK; Gerds TA; Fosbøl EL; Torp-Pedersen C; Gislason GH
Ann Intern Med; 2014 Nov; 161(10):690-8. PubMed ID: 25402512
[TBL] [Abstract][Full Text] [Related]
9. Effectiveness and Safety of Non-vitamin K Antagonist Oral Anticoagulants for Atrial Fibrillation and Venous Thromboembolism: A Systematic Review and Meta-analyses.
Almutairi AR; Zhou L; Gellad WF; Lee JK; Slack MK; Martin JR; Lo-Ciganic WH
Clin Ther; 2017 Jul; 39(7):1456-1478.e36. PubMed ID: 28668628
[TBL] [Abstract][Full Text] [Related]
10. Quality of life and patient satisfaction in patients with atrial fibrillation on stable vitamin K antagonist treatment or switched to a non-vitamin K antagonist oral anticoagulant during a 1-year follow-up: A PREFER in AF Registry substudy.
De Caterina R; Brüggenjürgen B; Darius H; Köhler S; Lucerna M; Pecen L; Renda G; Schilling RJ; Schliephacke T; Zamorano JL; Le Heuzey JY; Kirchhof P
Arch Cardiovasc Dis; 2018 Feb; 111(2):74-84. PubMed ID: 28942115
[TBL] [Abstract][Full Text] [Related]
11. The Impact of Polypharmacy on the Effectiveness and Safety of Non-vitamin K Antagonist Oral Anticoagulants in Patients with Atrial Fibrillation.
Grymonprez M; Petrovic M; De Backer TL; Steurbaut S; Lahousse L
Thromb Haemost; 2024 Feb; 124(2):135-148. PubMed ID: 37369234
[TBL] [Abstract][Full Text] [Related]
12. Oral Anticoagulation in Very Elderly Patients With Atrial Fibrillation: A Nationwide Cohort Study.
Chao TF; Liu CJ; Lin YJ; Chang SL; Lo LW; Hu YF; Tuan TC; Liao JN; Chung FP; Chen TJ; Lip GYH; Chen SA
Circulation; 2018 Jul; 138(1):37-47. PubMed ID: 29490992
[TBL] [Abstract][Full Text] [Related]
13. Concomitant Oral Anticoagulant and Nonsteroidal Anti-Inflammatory Drug Therapy in Patients With Atrial Fibrillation.
Kent AP; Brueckmann M; Fraessdorf M; Connolly SJ; Yusuf S; Eikelboom JW; Oldgren J; Reilly PA; Wallentin L; Ezekowitz MD
J Am Coll Cardiol; 2018 Jul; 72(3):255-267. PubMed ID: 30012318
[TBL] [Abstract][Full Text] [Related]
14. Racial Disparity in the Prescription of Anticoagulants and Risk of Stroke and Bleeding in Atrial Fibrillation Patients.
Tedla YG; Schwartz SM; Silberman P; Greenland P; Passman RS
J Stroke Cerebrovasc Dis; 2020 May; 29(5):104718. PubMed ID: 32122777
[TBL] [Abstract][Full Text] [Related]
15. Adherence with oral anticoagulation in non-valvular atrial fibrillation: a comparison of vitamin K antagonists and non-vitamin K antagonists.
Sørensen R; Jamie Nielsen B; Langtved Pallisgaard J; Ji-Young Lee C; Torp-Pedersen C
Eur Heart J Cardiovasc Pharmacother; 2017 Jul; 3(3):151-156. PubMed ID: 28158553
[TBL] [Abstract][Full Text] [Related]
16. Incidence of bleeding in patients with atrial fibrillation and advanced liver fibrosis on treatment with vitamin K or non-vitamin K antagonist oral anticoagulants.
Pastori D; Lip GYH; Farcomeni A; Del Sole F; Sciacqua A; Perticone F; Marcucci R; Grifoni E; Pignatelli P; Violi F;
Int J Cardiol; 2018 Aug; 264():58-63. PubMed ID: 29776574
[TBL] [Abstract][Full Text] [Related]
17. NSAIDs are associated with increased risk of atrial fibrillation in patients with prior myocardial infarction: a nationwide study.
Schjerning Olsen AM; Fosbøl EL; Pallisgaard J; Lindhardsen J; Lock Hansen M; Køber L; Hansen PR; Torp-Pedersen C; Gislason GH
Eur Heart J Cardiovasc Pharmacother; 2015 Apr; 1(2):107-14. PubMed ID: 27533979
[TBL] [Abstract][Full Text] [Related]
18. Resumption of oral anticoagulation following traumatic injury and risk of stroke and bleeding in patients with atrial fibrillation: a nationwide cohort study.
Staerk L; Fosbøl EL; Lamberts M; Bonde AN; Gadsbøll K; Sindet-Pedersen C; Holm EA; Gerds TA; Ozenne B; Lip GYH; Torp-Pedersen C; Gislason GH; Olesen JB
Eur Heart J; 2018 May; 39(19):1698-1705a. PubMed ID: 29165556
[TBL] [Abstract][Full Text] [Related]
19. Non-vitamin K Antagonist Oral Anticoagulants (NOACs) Versus Warfarin in Patients with Atrial Fibrillation Using P-gp and/or CYP450-Interacting Drugs: a Systematic Review and Meta-analysis.
Grymonprez M; Vanspranghe K; Steurbaut S; De Backer TL; Lahousse L
Cardiovasc Drugs Ther; 2023 Aug; 37(4):781-791. PubMed ID: 34637052
[TBL] [Abstract][Full Text] [Related]
20. Risk analysis of new oral anticoagulants for gastrointestinal bleeding and intracranial hemorrhage in atrial fibrillation patients: a systematic review and network meta-analysis.
Xu WW; Hu SJ; Wu T
J Zhejiang Univ Sci B; 2017 Jul; 18(7):567-576. PubMed ID: 28681581
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
